SCHEMBL9720

SCHEMBL9720

C#CCCCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15124812 0.92
SCHEMBL4235132 0.90 CYP1A2 (0.67)
SCHEMBL27988568 0.90 CYP1A2 (0.67)
SCHEMBL4231630 0.90 CYP1A2 (0.67)
SCHEMBL15124720 0.90 CYP1A2 (0.67)
SCHEMBL30836939 0.90 CYP1A2 (0.67)
SCHEMBL233701 0.86
SCHEMBL27809378 0.80 CYP1A2 (0.54)
SCHEMBL9086 0.78
SCHEMBL1308391 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491037-A1 COMPOUNDS Respivert Limited (GB) 2012-08-29 EP claimed
WO-2011048111-A1 COMPOUNDS RESPIVERT LIMITED (GB) 2011-04-28 WO claimed
US-20250223280-A1 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-07-10 US disclosed
US-12312340-B2 Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins AVILAR THERAPEUTICS, INC. (US) 2025-05-27 US disclosed
CN-120035588-A Aromatic acetylene derivative, preparation method and medical application thereof 浙江海正药业股份有限公司 2025-05-23 CN disclosed
CN-119306732-B Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-04-25 CN disclosed
US-20250129118-A1 MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE H LEE MOFFITT CANCER CT & RES (US) 2025-04-24 US disclosed
CN-113683622-B Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-02-18 CN disclosed
CN-119306732-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-01-14 CN disclosed
CN-119241554-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-01-03 CN disclosed
CN-119219654-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-12-31 CN disclosed
EP-1157019-A1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 F. HOFFMANN-LA ROCHE AG (CH) 2001-11-28 EP disclosed
US-6303793-B1 INTERMEDIATES FOR CYCLIN-DEPENDENT KINASE INHIBITORS HOFFMANN-LA ROCHE INC. 2001-10-16 US disclosed
US-6252086-B1 CYCLIN-DEPENDENT KINASES INHIBITORS; ANTICANCER AGENTS HOFFMANN-LA ROCHE INC. 2001-06-26 US disclosed
EP-0765879-B1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO CO (JP) 2001-02-14 EP disclosed
US-6130239-A INHIBIT CYCLIN-DEPENDENT KINASES HOFFMANN-LA ROCHE INC. (US) 2000-10-10 US disclosed
WO-2000035908-A1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed
US-5861429-A MITICIDES AND ANTHELMINTICS SANKYO COMPANY, LIMITED (JP) 1999-01-19 US disclosed
EP-0765879-A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO COMPANY LIMITED (JP) 1997-04-02 EP disclosed
EP-0361772-A2 Cyclopentyl ethers and their preparation and pharmaceutical formulation GLAXO GROUP LIMITED (GB) 1990-04-04 EP disclosed